ANGIOTENSIN - ANVISA Registration 10345162434

Access comprehensive regulatory information for ANGIOTENSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162434 and manufactured by SENTINEL CH. SPA. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including LTA SRL, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162434
Registration Details
ANVISA Registration Number: 10345162434
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família Atellica CH Enzima Conversora de Angiotensina (ECA)
Risk Class II

Registration Details

10345162434

25351074606202246

01449930000190

Company Information

SENTINEL CH. SPA
Italy
PT: ITÁLIA

Dates and Status

Mar 11, 2022

VIGENTE

09/18/2025 19:00:01